Table 3Symptomatic medications in withdrawal management

SymptomMedicationDoseRouteFrequencyContraindications
InsomniaTemazepam10-30 mgBy mouthAs required, before going to bedBenzodiazepine withdrawal
Promethazine25-75 mgBy mouthAs required, before going to bedBenzodiazepine withdrawal
Nausea +/-vomitingMetoclopramide10mgBy mouth
or
Intramuscular injection
Every 4-6 hours as required up to 3 times per dayDystonic reactions
Prochlorperazine5mgBy mouthUp to 3 times per day as requiredDystonic reactions
Abdominal crampsPropantheline15mgBy mouthUp to 3 times per day as required
Hyoscine Butylbromide20mgBy mouthUp to 3-4 times per day as required for up to 2-3 daysDiarrhoea caused by bacterial infection
DiarrhoeaKaolin mixture15-20 mlBy mouth4 times per day as required
Loperamide4mg initially,
then
2mg
By mouth4mg initially
then 2mg after each unformed stool up to a maximum of 16mg per day
Muscle crampsQuinine sulphate300mgBy mouth2 times per day as requiredAllergy to quinine
Headaches and other painsParacetamol/Codeine phosphate1000mg/16mgBy mouth
Paracetamol/Orhenadrine900mg/35mgBy mouth3 times per day
Paracetamol1000mgBy mouth4-6 hourly as required up to 4000mg per day
Ibuprofen400mgBy mouth3 times per day as requiredGastric ulcer
Gastritis
Asthma
CelecoxibBy mouth
Agitation, anxiety and restlessnessDiazepam5mgBy mouth2-3 times per day, reducing over 3-5 daysBenzodiazepine withdrawal

From: 4, Withdrawal Management

Cover of Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings
Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings.
Copyright © World Health Organization 2009.

All rights reserved.

Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob). Requests for permission to reproduce WHO publications, in part or in whole, or to translate them – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: tni.ohw@snoissimrep). For WHO Western Pacific Regional Publications, request for permission to reproduce should be addressed to Publications Office, World Health Organization, Regional Office for the Western Pacific, P.O. Box 2932, 1000, Manila, Philippines, fax: +632 521 1036, e-mail: tni.ohw.orpw@snoitacilbup

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.